MedCity News

APRIL 17, 2025

The post Eli Lillys Metabolic Medicine Takes the Lead in the Race to Develop an Oral GLP-1 Drug appeared first on MedCity News. The first Phase 3 results for Eli Lillys daily pill orforglipron show statistically significant reductions in blood sugar and body weight in patients with type 2 diabetes.

Medicine 235

Medicine Leads Pharmaceutical Patients 235

MedCity News

FEBRUARY 17, 2025

Tufts University, Kaiser Permanente and several other healthcare organizations recently launched the Food is Medicine National Network of Excellence. The network aims to develop, assess and share the best practices in the food-is-medicine space.

Food 200

Food Networking Medicine Healthcare 200

MedCity News

MARCH 27, 2025

Enhancing the accessibility of trustworthy medicines information and the availability of SRDs while also improving search technologies will ensure HCPs can quickly obtain accurate answers to their specific questions.

Medicine 218

Medicine Pharma Biopharma 218

MedCity News

APRIL 10, 2025

The post Alzheons Precision Medicine Approach to Resurrect an Alzheimers Drug Fails Pivotal Study appeared first on MedCity News. Alzheon hoped testing its drug in a genetically defined subgroup of Alzheimers disease patients would succeed, overcoming earlier clinical trial failures.

Medicine 179

Medicine Patients Biopharma Pharma 179

MedCity News

OCTOBER 30, 2024

After the FDA delayed the approval of MDMA-assisted therapy for PTSD, there’s still a way forward for psychedelic medicines, experts said at HLTH. The post What’s Next for Psychedelic Medicines? appeared first on MedCity News.

Medicine 331

Medicine FDA 331

MedCity News

NOVEMBER 15, 2024

To ramp up its food-as-medicine support, NationsBenefits has acquired Good Measures, a company that offers coaching and personalized food prescriptions. The post NationsBenefits Acquires Good Measures to Advance Food-as-Medicine Offerings appeared first on MedCity News.

Food 319

Food Medicine Prescription 319

MedCity News

AUGUST 15, 2024

The post Good Measures, Point32Health Launch Food as Medicine Partnership appeared first on MedCity News. Through a new partnership with Good Measures, some Point32Health members have gained access to nutrition counseling, food tracking and other services.

Food 306

Food Medicine 306

MedCity News

OCTOBER 2, 2024

Lilly Medicine Foundry will research new ways to manufacture medicines. Medicine Foundry to Foster Innovations in Drug Manufacturing appeared first on MedCity News. The post Eli Lilly Plans $4.5B

Manufacturing 305

Manufacturing Medicine Biopharma Pharma 305

MedCity News

APRIL 12, 2024

Kaiser Permanente’s new Food is Medicine Center of Excellence will “combine clinical services, research, education and community engagement,” according to the organization. The post Kaiser Permanente Unveils Food is Medicine Center of Excellence appeared first on MedCity News.

Food 298

Food Medicine Education 298

MedCity News

MAY 9, 2024

One irony of personalized or precision medicine (PM) is that it aims, against the advice of Hippocrates and Osler, to treat the disease, not the patient. The post Why Personalized Medicine Should Not Be Too Personalized appeared first on MedCity News.

Medicine 290

Medicine Patients Biopharma 290

Fierce Pharma

DECEMBER 12, 2023

Tuesday, the European Medicines Agency laid out a list of more than 300 critical generic drugs that could fall prey to future shortages. Over the past several years, drug shortages have vexed doctors and patients on both sides of the Atlantic, prompting lawmakers and government agencies to take action in both Europe and the U.S.

Medicine 360

Medicine Doctors Government Patients 360

MedCity News

AUGUST 5, 2024

During a webinar hosted by PitchBook, healthcare experts shared that the food-as-medicine space will likely see consolidation in the future, as well as advancements in technology and reimbursement. The post What Does the Future of the Food-As-Medicine Market Look Like? appeared first on MedCity News.

Food 278

Food Medicine Marketing Healthcare 278

MedCity News

AUGUST 8, 2024

The post Blue Cross Blue Shield of Tennessee Taps FarmboxRx for Food as Medicine Initiative appeared first on MedCity News. Through a new partnership with FarmboxRx, Blue Cross Blue Shield of Tennessee members will receive healthy food deliveries after they complete preventive health screenings, like a diabetic eye exam.

Food 299

Food Medicine 299

MedCity News

JANUARY 28, 2024

As the food as medicine movement grows, some payers and healthcare organizations are carving out specific roles and teams dedicated to food and nutrition. Doing so can be beneficial considering the significant impact diet can have on health outcomes.

Food 347

Food Medicine Healthcare Healthcare 347

MedCity News

SEPTEMBER 30, 2024

Bristol Myers Squibb is turning to the prime-editing technology of Prime Medicines for the R&D of new cell therapies for cancer and immunology. The post Gene-Editing Biotech Prime Medicine Strikes Up Cell Therapy R&D Alliance With Bristol Myers Squibb appeared first on MedCity News.

Medicine 289

Medicine Pharma Biopharma 289

MedCity News

NOVEMBER 14, 2024

Merck is acquiring global rights to a bispecific antibody from LaNova Medicines that blocks two cancer targets, PD-1 and VEGF. The deal comes one day after BioNTech announced an $800 million acquisition that gives it full rights to a molecule in this hot class of cancer drug candidates.

Medicine 306

Medicine Biopharma Pharma 306

MedCity News

JULY 15, 2024

Revolution Medicines drug RMC-6236 increased progression-free survival in patients with advanced cases of pancreatic ductal adenocarcinoma. The post Positive Data in Pancreatic Cancer Pave Way for Pivotal Test of Revolution Medicines Drug appeared first on MedCity News.

Medicine 278

Medicine Patients Biopharma 278

MedCity News

JANUARY 6, 2025

Orbis Medicines Series A round of funding was led by New Enterprise Associates. The startup is developing oral macrocyclic drugs for targets validated by blockbuster biologic medications that must be administered by injection.

Medicine 293

Medicine Medical Biopharma 293

MedCity News

OCTOBER 22, 2024

Editas Medicine says its in vivo gene-editing therapy for hemoglobinopathies has best-in-class potential, but the company plans to out-license or partner that program. The post Editas Medicine Seeks Partner for Ex Vivo Gene-Editing Program as Focus Turns to In Vivo R&D appeared first on MedCity News.

Medicine 289

Medicine Biopharma Pharma 289

Fierce Pharma

OCTOBER 31, 2024

25 mg presentation of the popular metabolic medicine was the last dose of either Wegovy or its type 2 diabetes sibling Ozempic to be listed as in shortage by the FDA. 25 mg starter dose of Novo’s semaglutide-based obesity med Wegovy is now available in the U.S.

FDA 332

FDA Medicine 332

MedCity News

NOVEMBER 10, 2024

By fostering collaboration and seamless data integration into healthcare systems, the industry is laying the groundwork for a future in which “personalized medicine” is so commonplace within clinical practice that we will just start calling it “medicine.”

Patients 311

Patients Medicine Healthcare Healthcare 311

MedCity News

MARCH 4, 2024

Food-as-medicine executives are none too thrilled about his comments — they argue that the remarks underscore the dire need to increase public education about affordable, healthy meal planning. Kellogg CEO Gary Pilnick recently encouraged families struggling to put food on the table to turn to cereal as their go-to dinner option.

Food 317

Food Medicine Education 317

MedCity News

FEBRUARY 29, 2024

Orbis Medicines is developing macrocyclic peptides that address a wider range of targets and can be taken as oral pills. Novo Holdings and Forbion are backing the startup, which is based on research from the scientific co-founder of peptide drug developer Bicycle Therapeutics.

Medicine 289

Medicine Biopharma Pharma 289

European Pharmaceutical Review

JUNE 18, 2025

in a deal set to advance genetic medicines for individuals at risk of cardiovascular disease. Verve’s pipeline involves gene editing medicines designed to address the drivers of atherosclerotic cardiovascular disease (ASCVD) and could be suitable for individuals with heterozygous familial hypercholesterolemia (HeFH), the firm shared.

Medicine 92

Medicine Leads Patients Pharmaceutical 92

MedCity News

APRIL 25, 2024

The post Regeneron Bets $100M That Mammoth’s CRISPR Tech Can Deliver on Next Wave of Genetic Medicines appeared first on MedCity News. The deal marks the third pharmaceutical industry partnership for Mammoth, which initially focused on developing CRISPR-based diagnostics.

Medicine 336

Medicine Pharmaceutical Biopharma Pharma 336

MedCity News

JANUARY 10, 2025

Ouro Medicines drugs deplete disease-driving immune cells, allowing the immune system to reset with nave cells that dont attack the body. Monograph Capital founded the startup in partnership with GSK. The post Immunology Startup Ouro Sets Out With $120M for Drugs That Reset the Immune System appeared first on MedCity News.

Medicine 262

Medicine Biopharma Pharma 262

MedCity News

MARCH 26, 2024

During a panel discussion on GLP-1s at the Abarca Forward conference, one health executive stressed the importance of a food-as-medicine approach.

Food 299

Food Medicine Healthcare Healthcare 299

MedCity News

MAY 17, 2024

The post The Lure of Specialty Medicine Pulls Nurse Practitioners From Primary Care appeared first on MedCity News. This development worries some people who track the health workforce, because current trends suggest primary care, soon might not be able to rely on them to mitigate the physician shortage.

Medicine 299

Medicine Physicians 299

MedCity News

NOVEMBER 8, 2024

Use of this ingredient in cold and allergy medicines grew after a federal law required that pseudoephedrine-containing products be kept behind pharmacy counters. The FDA has proposed removing oral phenylephrine from its guidelines for over-the-counter drugs due to inefficacy as a decongestant.

FDA 306

FDA Marketing Medicine Biopharma 306

MedCity News

DECEMBER 22, 2024

The new approval gives the Eli Lilly medicine the opportunity to become a blockbuster seller in yet another indication. Zepbounds clinical tests in obstructive sleep apnea showed improvement in breathing disruptions that were accompanied by reductions in body weight.

FDA 287

FDA Medicine Biopharma Pharma 287

European Pharmaceutical Review

NOVEMBER 6, 2024

Dupixent (dupilumab) has been approved by the European Medicines Agency (EMA) as the first treatment for young children with eosinophilic esophagitis in the EU. The medicine has been jointly developed by Sanofi and Regeneron. This result was maintained for up to one year.

Medicine 105

Medicine Patients Pharmaceutical 105

Fierce Pharma

OCTOBER 25, 2024

The FDA nod marks the second approval this year for a uUTI medicine after two decades of stagnation in the field. . | Iterum's Orlynvah was approved by the FDA Friday to treat certain uncomplicated urinary tract infections (uUTIs) in adult women who have limited or no alternative antibacterial treatment options.

FDA 301

FDA Medicine 301

MedCity News

FEBRUARY 2, 2025

Investors showed appetite for Metseras IPO, as shares of the clinical-stage metabolic medicines biotech popped 47% in their Nasdaq debut. Maze Therapeutics and Beta Bionics also priced IPOs; the three companies raised $636 million combined.

Medicine 297

Medicine Biopharma Pharma 297

MedCity News

JANUARY 8, 2025

Metabolic medicines dominated life sciences headlines in 2024, a trend expected to continue into the new year. Other things to look for include more widespread adoption of artificial intelligence technologies and the IPO markets return to normal levels.

Biopharma 311

Biopharma Medicine Marketing FDA 311

Fierce Pharma

NOVEMBER 1, 2024

With a positive readout for metabolic dysfunction-associated steatohepatitis (MASH) now in the bag, Novo Nordisk is gearing up to pursue yet another indication for its star GLP-1 medicine semagluti | Novo Nordisk on Friday revealed that its star GLP-1 semaglutide met the mark in a late-stage MASH study.

Medicine 337

Medicine 337

Fierce Pharma

NOVEMBER 15, 2024

In a flurry of activity, Europe’s human medicines committee has done an about-face on Eisai and Biogen’s Alzheimer’s disease med Leqembi, endorsed a clutch of biosimilars, recommended a slew of lab | In a flurry of activity, the European Medicines Agency's CHMP has done an about-face on Eisai and Biogen’s Alzheimer’s disease med Leqembi, endorsed (..)

Medicine 272

Medicine 272

Fierce Pharma

DECEMBER 17, 2024

| After the recent release of two independent studies from the University of Southern Denmark suggested the use of Ozempic increases patients' chances of developing a rare eye disorder, the Danish Medicines Agency has asked European officials to investigate.

Medicine 274

Medicine Patients 274